Posted April 11, 2012 on drugwatch As more women who have been victim to faulty transvaginal mesh devices across the United States come forward, medical device regulators here and in the United Kingdom continue their sluggish investigations into devices that have caused severe injuries and death. In the past months, the U.S. Food and Drug Full Article…
Search LawsuitInformation.org
Bayer Begins Settling Yaz Side Effect Lawsuits
Posted April 11, 2012 on PRWeb Dallas, TX (PRWEB) April 11, 2012 With thousands of trials over alleged side effects from the birth control drugs Yaz and Yasmin set to begin, news came recently that the maker of the drugs had begun efforts to settle some of the outstanding cases. According to a federal Multi-District Full Article…
Consumer Reports: Most Medical Implants Have Never Been Tested for Safety
Posted March 30, 2012 by InjuryBoard An investigation of medical devices on the market in the United States shows that most have little, if any testing to prove their safety and effectiveness, according to Consumer Reports, an independent, non-profit organization focused on consumer advocacy regarding the safety and reliability of products in the marketplace. Consumer Full Article…
St. Louis-based Carey Danis & Lowe Announces Suit Against the Maker of Zoloft
Posted February 29, 2012 by Carey & Danis Alleges Pfizer hid birth defect risks to pregnant mothers prescribed the antidepressant ST. LOUIS, Feb 06, 2012 (BUSINESS WIRE) — St. Louis–based law firm Carey, Danis & Lowe announces the filing of a lawsuit on behalf of 18 plaintiffs against Pfizer PFE -0.04% , maker of the Full Article…
Mesh Implant Update: FDA Requires More Studies and Information From Manufacturers
Posted February 12, 2012 by InjuryBoard Blog Following up on previous warnings about the safety of transvaginal mesh implants to treat pelvic organ prolapse, the FDA is now enlisting the research power of the manufacturers of these devices. On January 3, the FDA sent letters to 35 manufacturers of surgical mesh implants, mandating them to Full Article…
Drug Headlines of 2011
Posted December 20, 2011 by The Scientist A list of this year’s newsworthy successes—and failures—in drug development Developing new medicines is tricky business, requiring sound science, regulatory savvy, and marketing skills. The past year has seen success and failure in all these realms. Here, The Scientist recounts some of the noteworthy drug developments of 2011. Full Article…
Drug Approvals Up for 2011
Posted January 9, 2012 by The Scientist The FDA approved 30 drugs last year, the highest number in the last 7 years. The US Food and Drug Administration approved 30 drugs in 2011, compared with 21 in 2010, according to an analysis by Bloomberg News. That number is the highest since 36 drugs were approved Full Article…
J&J, C.R. Bard Must Study Safety of Vaginal Mesh, FDA Says
Posted January 5, 2012 by Bloomberg Johnson & Johnson (JNJ) and C.R. Bard Inc. (BCR) must study rates of organ damage and complications linked to vaginal mesh implants, U.S. regulators said, responding to patient advocates who say the devices have harmed women. The Food and Drug Administration wrote J&J, C.R. Bard and 31 other manufacturers, Full Article…
Lights Out for Bayer’s YAZ?
Posted January 6, 2012 by InjuryBoard Bayer AG, Germany’s largest drugmaker, blinked and swallowed hard, at the end of December, when it begged the Court overseeing the YAZ litigation. ayer managed to avoid the first trial which was set to start January 9th, over claims its birth-control pills caused blood clots after Judge Hearndon appointed Full Article…
FDA Announces 10 Drugs With Severe Birth Defect Warnings
Posted January 10, 2012 by SB Wire San Diego, CA — (SBWIRE) — 01/10/2012 – The drugs found on this list went through multiple tests, research experiments, and survey before the FDA classified them as dangerous to babies during pregnancy. Zoloft (sertraline), a popular antidepressant known as a “selective serotonin reuptake inhibitor” (SSRI), is linked Full Article…
